Learn more about our Payment & Health Care Delivery Policy work.
WASHINGTON—AdvaMed, the MedTech Association®, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft…
WASHINGTON—AdvaMed, the MedTech Association®, today welcomed U.S. House of Representatives Committee on Ways and Means passage of legislation providing Medicare coverage of FDA-designated and authorized breakthrough medtech.AdvaMed® also urged legislators…
WASHINGTON—AdvaMed, the MedTech Association®, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health…
WASHINGTON—AdvaMed, the MedTech Association®, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act…
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart…
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, is among 67 stakeholder groups, including patient advocacy groups and state medtech and life sciences associations, urging the Centers for Medicare and Medicaid Services (CMS)…
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, laid out medtech’s vital role in the Trump administration’s…
Focusing on pelvic health, maternity care, and mental health, this White Paper uncovers structural barriers and highlights opportunities to advance equity in women’s health.
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…